Le linee Guida ACCP del 2012 ("Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines") in gravidanza raccomandano di evitare l'uso di: dabigatran, rivaroxaban e apixaban.